Pathology in prostate research: Optimizing the pathological data

Acta Oncologica

Volumn 50, Issue SUPPL. 1, 2011, Pages 49-52

  Berney, Daniel M ^a   Montironi, Rodolfo ^b   Egevad, Lars ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RESEARCH; CANCER STAGING; DIAGNOSTIC ERROR; GLEASON SCORE; HUMAN; METASTASIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW; SEMINAL VESICLE DISEASE; TRANSURETHRAL RESECTION;

BIOMEDICAL RESEARCH; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; STATISTICS AS TOPIC;

EID: 79957472546     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.525223     Document Type: Review

References (30)

1. Bostwick DG, Chang L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol 1999;17:199-205. (Pubitemid 30030103)
2. Berney DM, Fisher G, Kattan MW, Oliver RT, Moller H, Fearn P, et al. Pitfalls in the diagnosis of prostatic cancer: Retrospective review of 1791 cases with clinical outcome. Histopathology 2007;51:452-7. (Pubitemid 47437843)
3. Wojno KJ, Epstein JI. The utility of basal cell-specifi c anticytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 1995;19:251-60.
4. Epstein JI, Walsh PC, Sanfi lippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol 1996;20:851-7. (Pubitemid 26230748)
5. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-507. (Pubitemid 29220858)
6. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095-101. (Pubitemid 40617061)
7. Epstein JI, Allsbrook WC, Jr., Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29:1228-42. (Pubitemid 41232997)
8. Zareba P, Zhang J, Yilmaz A, Trpkov K. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice. Histopathology 2009;55:384-91.
9. Melia J, Moseley R, Ball RY, Griffi ths DF, Grigor K, H arnden P, et al. A UK-based investigation of inter-and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology 2006;48:644-54.
10. Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005;97: 1248-53. (Pubitemid 41535365)
11. Harnden P, Shelley MD, Coles B, Staffurth J, Mason MD. Should the Gleason grading system for prostate cancer be modifi ed to account for high-grade tertiary components? A systematic review and meta-analysis. Lancet Oncol 2007;8:411-9. (Pubitemid 46621769)
12. Berney DM, Fisher G, Kattan MW, Oliver RT, Moller H, Fearn P, et al. Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. BJU Int 2007;100:1240-4.
13. Foucar E, Haake G, Dalton L, Pathak DR, Lujan JP. The area of cancer in transurethral resection specimens as a prognostic indicator in carcinoma of the prostate: A computerassisted morphometric study. Hum Pathol 1990;21:586-92. (Pubitemid 20204945)
14. Harnden P, Shelley MD, Naylor B, Coles B, Mason MD. Does the extent of carcinoma in prostatic biopsies predict prostate-specifi c antigen recurrence? A systematic review. Eur Urol 2008;54:728-39.
15. Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005;216:20-33.
16. Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, et al. The prognostic signifi cance of perineural invasion in prostatic cancer biopsies: A systematic review. Cancer 2007;109:13-24. (Pubitemid 46120190)
17. van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffi ths D, Humphrey PA, et al. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2010 Sep 3.
18. Tan PH, Cheng L, Srigley JR, Griffi ths D, Humphrey PA, van der Kwast TH, et al. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 5: Surgical margins. Mod Pathol 2010 Aug 20.
19. Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffi ths DF, van der Kwast TH, et al. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2010 Aug 27.
20. Egevad L, Srigley JR, Delahunt B. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens: Rationale and organization. Mod Pathol 2010 Aug 27.
21. Berney DM, Wheeler TM, Grignon DJ, Epstein JI, Griffi ths DF, Humphrey PA, et al. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 4: Seminal vesicles and lymph nodes. Mod Pathol 2010 Sep 3.
22. Epstein JI, Amin M, Boccon-Gibod L, Egevad L, Humphrey PA, Mikuz G, et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005;216: 34-63.
23. Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Jr., et al. Tumour volume is an independent predictor of prostate-specifi c antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006;97:1169-72. (Pubitemid 43907315)
24. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004;172:508-11. (Pubitemid 38900191)
25. Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. The relationship between the extent of surgical margin positivity and prostate specifi c antigen recurrence in radical prostatectomy specimens. Hum Pathol 2007;38:1207-11. (Pubitemid 47058159)
26. Babaian RJ, Troncoso P, Bhadkamkar VA, Johnston DA. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 2001;91:1414-22. (Pubitemid 32319250)
27. Tefi lli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon DJ, et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol, 1998, 160 (3 Pt 1), 802-6. (Pubitemid 29479518)
28. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Vascular invasion predicts recurrence after radical prostatectomy: Stratifi cation of risk based on pathologic variables. Urology 2004;64:749-53. (Pubitemid 39446056)
29. Cheng L, Bergstralh EJ, Cheville JC, Slezak J, Corica FA, Zincke H, et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol 1998;22:1491-500. (Pubitemid 28550644)
30. Cheng L, Pisansky TM, Ramnani DM, Leibovich BC, Cheville JC, Slezak J, et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol 2000;13:113-8. (Pubitemid 30109096)